Abrilada (Adalimumab-afzb)

Overview

Abrilada is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat plaque psoriasis and psoriatic arthritis, as well as rheumatoid arthritis, juvenile idiopathic… read more

Acthar Gel (Repository Corticotropin Injection)

Overview
Acthar Gel is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat conditions including multiple sclerosis, psoriatic arthritis, rheumatoid arthritis, and lupus. Acthar Gel is… read more

Amjevita (Adalimumab-atto)

Overview
Amjevita is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat active psoriatic arthritis and moderate to severe chronic plaque psoriasis in adults. Amjevita may be… read more

Bimzelx (Bimekizumab-Bkzx)

Bimzelx (bimekizumab-bkzx) is a biologic medication approved by the U.S. Food and Drug Administration (FDA) for treating moderate to severe psoriasis in…

Calcitrene (Calcipotriene)

Overview
Calcitrene is approved by the U.S. Food and Drug Administration (FDA) for the treatment of plaque psoriasis in adults. It is prescribed for individuals with mild to moderate plaque psoriasis and should not be…

Cimzia (Certolizumab Pegol) for Psoriasis

Cimzia (certolizumab pegol) is a biologic medication approved by the U.S. Food and Drug Administration (FDA) for treating moderate to severe plaque…

Cosentyx (Secukinumab) for Psoriasis

Cosentyx (secukinumab) is a biologic medicine approved by the U.S. Food and Drug Administration (FDA) to treat moderate to severe plaque psoriasis in…

Dovonex (Calcipotriene)

Overview
Dovonex is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat plaque psoriasis. Dovonex is also known by its drug name calcipotriene.

Calcipotriene, the active… read more

Duobrii (Halobetasol propionate/Tazarotene)

Overview
Duobrii is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat plaque psoriasis in people ages 18 and older. Duobrii is a combination drug composed of halobetasol propionate and… read more

Enbrel (Etanercept) for Psoriasis

Enbrel (etanercept) is a biologic medication approved by the U.S. Food and Drug Administration (FDA) for treating moderate to severe psoriasis in adults…

Erelzi (Etanercept-szzs)

Overview
Erelzi is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat psoriatic arthritis and moderate to severe chronic plaque psoriasis in adults. Erelzi may be referred to by… read more

Hadlima (Adalimumab-bwwd)

Overview
Hadlima is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults with moderate to severe plaque psoriasis and active psoriatic arthritis. Hadlima is also known by its drug… read more

Hulio (Adalimumab-fkjp)

Overview
Hulio is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults with moderate to severe plaque psoriasis and active psoriatic arthritis. Hulio is also referred to by its… read more

Humira (Adalimumab)

Humira (adalimumab) is a biologic medication approved by the U.S. Food and Drug Administration (FDA) for treating moderate to severe psoriasis in adults. 

Hyrimoz (Adalimumab-adaz)

Overview
Hyrimoz is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults with moderate to severe plaque psoriasis and active psoriatic arthritis. Hyrimoz is also approved to treat… read more

Icotyde (Icotrokinra) for Psoriasis

Icotyde (icotrokinra) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) for treating adults and children aged 12 years and older with moderate to severe…

Ilumya (Tildrakizumab-asmn)

Overview
Ilumya is approved by the U.S. Food and Drug Administration (FDA) to treat adults with moderate to severe plaque psoriasis in cases where systemic therapy or phototherapy are warranted. Ilumya is also referred… read more

Imuldosa (Ustekinumab-Srlf)

Overview
Imuldosa is approved by the U.S. Food and Drug Administration (FDA) for treating moderate to severe plaque psoriasis in people ages 6 years and older who are candidates for phototherapy (light therapy) or…

Inflectra (Infliximab-dyyb)

Overview
Inflectra is a prescription medication approved by the U.S. Food and Drug Administration (FDA) for the treatment of active psoriatic arthritis and chronic severe plaque psoriasis. In cases of plaque psoriasis,… read more

Ixifi (Infliximab-qbtx)

Overview
Ixifi is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults with plaque psoriasis and psoriatic arthritis. Ixifi is also referred to by its drug name, infliximab-qbtx.… read more